Evidence map›Paper›PMID 31477774›Full record

ArticleScientific reports2019

Design and characterization of dual drug delivery based on in-situ assembled PVA/PAN core-shell nanofibers for wound dressing application.

Davood Kharaghani, Parastoo Gitigard, Hijiri Ohtani, Kyu Oh Kim, Sana Ullah, Yusuke Saito, Muhammad Qamar Khan, Ick Soo Kim

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Efficacy of Platelet-Rich Plasma and Polyvinyl Alcohol Wound Dressing in Open Wound Healing: First Results from an Experimental Rat Model.European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Electrospun Nanofibers for Wound Management.ChemNanoMat : chemistry of nanomaterials for energy, biology and more · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Dual drug delivery platforms for bone tissue engineering.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Davood KharaghaniNano Fusion Technology Research Group, Division of Frontier Fibers, Institute for Fiber Engineering (IFES-, Interdisciplinary Cluster for Cutting Edge Research) ICCER, Shinshu University, Tokida 3-15-1, Ueda, Nagano, 386-8567, Japan.
Parastoo GitigardNano Fusion Technology Research Group, Division of Frontier Fibers, Institute for Fiber Engineering (IFES-, Interdisciplinary Cluster for Cutting Edge Research) ICCER, Shinshu University, Tokida 3-15-1, Ueda, Nagano, 386-8567, Japan.
Hijiri OhtaniNano Fusion Technology Research Group, Division of Frontier Fibers, Institute for Fiber Engineering (IFES-, Interdisciplinary Cluster for Cutting Edge Research) ICCER, Shinshu University, Tokida 3-15-1, Ueda, Nagano, 386-8567, Japan.
Kyu Oh KimDepartment of Fiber System Engineering, Dankook University, Gyeonggi-do, Republic of Korea.
Sana UllahNano Fusion Technology Research Group, Division of Frontier Fibers, Institute for Fiber Engineering (IFES-, Interdisciplinary Cluster for Cutting Edge Research) ICCER, Shinshu University, Tokida 3-15-1, Ueda, Nagano, 386-8567, Japan.
Yusuke SaitoNano Fusion Technology Research Group, Division of Frontier Fibers, Institute for Fiber Engineering (IFES-, Interdisciplinary Cluster for Cutting Edge Research) ICCER, Shinshu University, Tokida 3-15-1, Ueda, Nagano, 386-8567, Japan.
Muhammad Qamar KhanNano Fusion Technology Research Group, Division of Frontier Fibers, Institute for Fiber Engineering (IFES-, Interdisciplinary Cluster for Cutting Edge Research) ICCER, Shinshu University, Tokida 3-15-1, Ueda, Nagano, 386-8567, Japan.
Ick Soo KimNano Fusion Technology Research Group, Division of Frontier Fibers, Institute for Fiber Engineering (IFES-, Interdisciplinary Cluster for Cutting Edge Research) ICCER, Shinshu University, Tokida 3-15-1, Ueda, Nagano, 386-8567, Japan. kim@shinshu-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Core-shell nanofibers with the ability to carry multiple drugs are attracting the attention to develop appropriate drug delivery systems for wounds dressing applications. In this study, biocompatible core-shell nanofibers have been designed as a promising dual-drug carrier with the capability of delivering both water-soluble and organic solvent-soluble drugs simultaneously. With the aim of fabricating the core-shell nanofibers, the dipping method has been employed. For this propose, core nanofibers made from polyvinyl alcohol (PVA) were immersed in various concentrations of polyacrylonitrile (PAN) and cross-linked by dipping into ethanol. Diclofenac sodium salt (DSs) and gentamicin sulfate (GENs) have been loaded into the core and shell nanofibers as models of the drug, respectively. The morphology study of core-shell nanofibers showed that the concentrations between 1% w/w up to 2% w/w PAN/GENs, with deep penetration into the internal layers of PAV/DSs nanofibers could lead to the core-shell structure. The cytotoxicity results showed the competency of designed core-shell nanofibers for wound dressing application. Also, the release profile exhibits the controllable behavior of drug release.

Indexed as

BandagesDrug Delivery SystemsAcrylic ResinsCell AdhesionCell DeathCross-Linking ReagentsDiclofenacDrug LiberationNanofibersPhotoelectron SpectroscopyPolyvinyl AlcoholSpectroscopy, Fourier Transform InfraredTemperatureThermogravimetryWounds and InjuriesAcrylic ResinsCross-Linking ReagentsDiclofenacpolyacrylonitrilePolyvinyl Alcohol

Identifiers

PMID31477774
PMCPMC6718412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.